Linaprazan (AZD0865) can inhibit H+,K+ -ATPase in the stomach through K+ competitive binding, (IC50: 1.0 0.2 µM), it has a strong inhibitory effect on acid. Linaprazan (AZD0865) can be used for research on reflux esophagitis with oral activity[1][2][3].
Molecular Weight:
366.46
Purity:
98.80
CAS Number:
[248919-64-4]
Formula:
C21H26N4O2
Target:
Proton Pump
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted